Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report published on Monday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Trading Up 376.2 %

Shares of AMPE opened at $0.01 on Monday. The company has a market cap of $11,400.00, a price-to-earnings ratio of 0.00 and a beta of 3.66. The company’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.